Vivos Therapeutics, Inc. (VVOS) Q2 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Vivos Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:05.413 Good day, everyone, and welcome to Vivos Therapeutics' second quarter 2023 00:00:05.413 -- 00:00:10.557 earnings conference call. At this time, all participants are in a listen-only 00:00:10.557 -- 00:00:15.281 mode. A question and answer session will follow management's remarks. 00:00:15.281 -- 00:00:19.965 This conference call is being recorded, and a replay of today's call will be available 00:00:19.965 -- 00:00:24.989 on the Investor Relations section of Vivos' website and will remain posted 00:00:24.989 -- 00:00:29.864 there for the next 30 days. I will now hand over the call. 00:00:29.864 -- 00:00:34.945 Julie Gannon vivos investor relations officer for introductions and the reading 00:00:34.945 -- 00:00:39.206 of the safe harbor statement please go ahead 00:00:39.286 -- 00:00:44.327 thank you operator hello everyone and welcome to our conference call a copy 00:00:44.327 -- 00:00:49.408 of our earnings press release is available on the investor relations section of our website 00:00:49.408 -- 00:00:51.888 at www.vivos.com 00:00:52.649 -- 00:00:57.770 with us on today's call are Kirk Huntsman vivos chairman and chief executive officer 00:00:57.770 -- 00:01:00.879 and and Brad Ammon, Chief Financial Officer. 00:01:00.879 -- 00:01:06.263 Today we'll review the highlights and financial results for the second quarter of 2023, 00:01:06.263 -- 00:01:11.326 as well as more recent developments and VEVO's plans for the remainder of 2023. 00:01:11.326 -- 00:01:15.369 Following these formal remarks, we will be happy to take questions. 00:01:15.369 -- 00:01:20.233 I would also like to remind everyone that today's call will contain certain forward-looking 00:01:20.233 -- 00:01:25.095 statements from our management, made within the meaning ...